Zobrazeno 1 - 10
of 210
pro vyhledávání: '"Marjolein van Ballegooijen"'
Autor:
Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202924 (2018)
BACKGROUND:Human papillomavirus (HPV) vaccination and the implementation of primary HPV screening in the Netherlands will lead to a lower cervical disease burden. For evaluation and further improvement of prevention, it is important to estimate the m
Externí odkaz:
https://doaj.org/article/3b82aed01b914272a04c306f9fcda0c3
Autor:
S Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G Zauber, Lawrence F Paszat, Jeffrey S Hoch, Jean H E Yong, Sonja Kroep, Jill Tinmouth, Iris Lansdorp-Vogelaar
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
BACKGROUND:The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less spe
Externí odkaz:
https://doaj.org/article/71e8c5880de84218a8ea982978a449b8
Autor:
Steffie K Naber, Suzette M Matthijsse, Kirsten Rozemeijer, Corine Penning, Inge M C M de Kok, Marjolein van Ballegooijen
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is e
Externí odkaz:
https://doaj.org/article/45345d27348749c3a4fa155db5c7931b
Autor:
Suzette M Matthijsse, Joost van Rosmalen, Jan A C Hontelez, Roel Bakker, Inge M C M de Kok, Marjolein van Ballegooijen, Sake J de Vlas
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116618 (2015)
BACKGROUND: Knowledge of the natural history of human papillomavirus (HPV), in particular the role of immunity, is crucial in estimating the (cost-) effectiveness of HPV vaccination and cervical cancer screening strategies, because naturally acquired
Externí odkaz:
https://doaj.org/article/b5e0d27d910b4d139f232f37e78a5e36
Autor:
Robine Hofman, Esther W de Bekker-Grob, Jan Hendrik Richardus, Harry J de Koning, Marjolein van Ballegooijen, Ida J Korfage
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104772 (2014)
To assess how girls' preferences have changed almost 3 years after the much debated start of the human papillomavirus (HPV) vaccination program.A discrete choice experiment (DCE) was conducted among girls aged 11-15 years who were invited, or were no
Externí odkaz:
https://doaj.org/article/69b84f8f475c42af9e8eeac20afe45a5
Autor:
E. Georg Luebeck, Chin Hur, John M. Inadomi, Eric J. Feuer, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Sung Eun Choi, Melecia C. Miller, Curtis R. Heberle, Rafael Meza, Jihyoun Jeon, William D. Hazelton, Kit Curtius, Sonja Kroep, Chung Yin Kong
PDF - 1235K, Referred to as "Appendix". Supplementary Materials and Methods. Figure A1. Schematic diagram of MSEAC Model. Figure A2. Cell Proliferation Rates by Birth Cohort, Males. Figure A3. Cell Proliferation Rates by Birth Cohort, Females. Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9e733dc85a8dbeaa7238092f25294c
https://doi.org/10.1158/1055-9965.22437597.v1
https://doi.org/10.1158/1055-9965.22437597.v1
Autor:
Ahmedin Jemal, Ann G. Zauber, Marjolein van Ballegooijen, Amy B. Knudsen, Karen M. Kuntz, Iris Lansdorp-Vogelaar
PDF file - 149K, Appendix containing detailed model description, estimates of survival by race, age and gender over time and Formulas for Calculation of Disparities and Proportion of Disparities Explained by Screening and Survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cddf0731aabc70110cc14107e30d03
https://doi.org/10.1158/1055-9965.22437078
https://doi.org/10.1158/1055-9965.22437078
Autor:
Marjolein van Ballegooijen, Joost van Rosmalen, Corine Penning, Folkert J. van Kemenade, Steffie K. Naber, Inge M.C.M de Kok, Kirsten Rozemeijer
Supplementary Tables 1-5, Figures 1-3. Supplementary Table 1 - Model assumptions for the age-specific probability of having had a hysterectomy for reasons other than cervical cancer, for women with birth years 1953-1992; Supplementary Table 2 - Trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb6237a778453b2287faf3b84f73f01
https://doi.org/10.1158/1055-9965.22437412
https://doi.org/10.1158/1055-9965.22437412
Autor:
Ahmedin Jemal, Ann G. Zauber, Marjolein van Ballegooijen, Amy B. Knudsen, Karen M. Kuntz, Iris Lansdorp-Vogelaar
Editorial for This Article from Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00b635c8953ac6bc0dc943ea61acf32
https://doi.org/10.1158/1055-9965.22437081.v1
https://doi.org/10.1158/1055-9965.22437081.v1
Autor:
Ahmedin Jemal, Ann G. Zauber, Marjolein van Ballegooijen, Amy B. Knudsen, Karen M. Kuntz, Iris Lansdorp-Vogelaar
Background: Considerable disparities exist in colorectal cancer (CRC) incidence and mortality rates between blacks and whites in the United States. We estimated how much of these disparities could be explained by differences in CRC screening and stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709f3f21cc6741443d6f68b62afd3e39
https://doi.org/10.1158/1055-9965.c.6515709.v1
https://doi.org/10.1158/1055-9965.c.6515709.v1